153 related articles for article (PubMed ID: 8242126)
1. Improvement in arterial stiffness during hypolipidaemic therapy is offset by weight gain.
Matthews PG; Wahlqvist ML; Marks SJ; Myers KA; Hodgson JM
Int J Obes Relat Metab Disord; 1993 Oct; 17(10):579-83. PubMed ID: 8242126
[TBL] [Abstract][Full Text] [Related]
2. Intima-media thickness after cholesterol lowering in familial hypercholesterolemia. A three-year ultrasound study of common carotid and femoral arteries.
Wendelhag I; Wiklund O; Wikstrand J
Atherosclerosis; 1995 Oct; 117(2):225-36. PubMed ID: 8801868
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia.
Lewis-Barned NJ; Ball MJ
N Z Med J; 1992 Jul; 105(938):284-6. PubMed ID: 1495661
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with simvastatin compared with cholestyramine.
Erkelens DW; Baggen MG; Van Doormaal JJ; Kettner M; Koningsberger JC; Mol MJ
Drugs; 1988; 36 Suppl 3():87-92. PubMed ID: 3254824
[TBL] [Abstract][Full Text] [Related]
5. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
Mol MJ; Stuyt PM; Demacker PN; Stalenhoef AF
Neth J Med; 1990 Apr; 36(3-4):182-90. PubMed ID: 2355995
[TBL] [Abstract][Full Text] [Related]
6. The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia.
Smilde TJ; van den Berkmortel FW; Wollersheim H; van Langen H; Kastelein JJ; Stalenhoef AF
Eur J Clin Invest; 2000 Jun; 30(6):473-80. PubMed ID: 10849014
[TBL] [Abstract][Full Text] [Related]
7. Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin.
de Sauvage Nolting PR; de Groot E; Zwinderman AH; Buirma RJ; Trip MD; Kastelein JJ
Arch Intern Med; 2003 Aug 11-25; 163(15):1837-41. PubMed ID: 12912721
[TBL] [Abstract][Full Text] [Related]
8. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
[TBL] [Abstract][Full Text] [Related]
9. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
Geisel J; Oette K; Burrichter H
Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia.
Wierzbicki AS; Lumb PJ; Cheung J; Crook MA
QJM; 1997 Oct; 90(10):631-4. PubMed ID: 9415344
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
[TBL] [Abstract][Full Text] [Related]
12. Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
Smit JW; Van Erpecum KJ; Portincasa P; Renooij W; Erkelens DW; Van Berge-Henegouwen GP
Gut; 1995 Nov; 37(5):654-9. PubMed ID: 8549941
[TBL] [Abstract][Full Text] [Related]
13. [Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia].
Aubert I; Emmerich J; Charpak Y; Chanu B; Dachet C; Herlich D; Besseau M; Rouffy J; Jacotot B
Presse Med; 1988 May; 17(18):901-4. PubMed ID: 2968595
[TBL] [Abstract][Full Text] [Related]
14. Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia.
Zhao SP; Hollaar L; van 't Hooft FM; Smelt AH; Gevers Leuven JA; van der Laarse A
Clin Chim Acta; 1991 Dec; 203(2-3):109-17. PubMed ID: 1777975
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of simvastatin (MK-733).
Stalenhoef AF; Mol MJ; Stuyt PM
Am J Med; 1989 Oct; 87(4A):39S-43S. PubMed ID: 2679083
[TBL] [Abstract][Full Text] [Related]
16. [Effects of simvastatin on atherogenic blood lipid pattern].
Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F
Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842
[TBL] [Abstract][Full Text] [Related]
17. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
O'Brien RC; Simons LA; Clifton P; Cooper ME; Jennings GL; Jerums G; Nestel PJ; Sullivan D
Med J Aust; 1990 May; 152(9):480-3. PubMed ID: 2199801
[TBL] [Abstract][Full Text] [Related]
18. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
[TBL] [Abstract][Full Text] [Related]
19. Low-dose simvastatin for the treatment of hypercholesterolaemia in recipients of cardiac transplantation.
Barbir M; Rose M; Kushwaha S; Akl S; Mitchell A; Yacoub M
Int J Cardiol; 1991 Nov; 33(2):241-6. PubMed ID: 1743784
[TBL] [Abstract][Full Text] [Related]
20. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia.
Jones DB; Simpson HC; Slaughter P; Lousley S; Carter RD; Cobbe SM; Mann JI
Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
